SCHEMBL31493448

SCHEMBL31493448

CC(=O)NC1CC2(C1)CC2F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.39
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 2/20 0.37
ALOX15 P16050 1/20 0.36
TLR4 O00206 1/20 0.34
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
DPP4 P27487 1/20 0.31
DPP8 Q6V1X1 1/20 0.31
CA1 P00915 3/20 0.31
CA2 P00918 3/20 0.31
GRM6 O15303 2/20 0.31
GRM2 Q14416 2/20 0.31
GRM3 Q14832 2/20 0.31
CA12 O43570 2/20 0.31
CA9 Q16790 1/20 0.31
GRM8 O00222 1/20 0.31
TACR1 P25103 1/20 0.30
TACR3 P29371 1/20 0.30
CA7 P43166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14904407 0.77 ATM (0.42) ATMALDH1A1KDM4EALOX15TLR4
SCHEMBL31493477 0.77 ATM (0.38) ATMALDH1A1KDM4EALOX15TLR4
Hydrochloric Acid SCHEMBL30777466 0.76 ATM (0.41) ATMALDH1A1KDM4EALOX15TLR4
SCHEMBL18214762 0.73 ATM (0.42) ATMALDH1A1KDM4EALOX15TLR4
SCHEMBL22482082 0.71 ATM (0.37) ATMALDH1A1KDM4EALOX15TLR4
SCHEMBL22482090 0.71 ATM (0.37) ATMALDH1A1KDM4EALOX15TLR4
SCHEMBL21603619 0.70
SCHEMBL15129736 0.70 ATM (0.54) ATMALDH1A1KDM4ETLR4MTNR1A
SCHEMBL25024421 0.70 ALOX15 (0.42) ATMALDH1A1KDM4EALOX15MTNR1A
SCHEMBL6604915 0.70 ATM (0.39) ATMALDH1A1KDM4EALOX15TLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137599-A1 WRN INHIBITORS NIMBUS WADJET, INC. (US) 2025-06-26 WO disclosed
US-20250206738-A1 WRN INHIBITORS NIMBUS DISCOVERY, INC. 2025-06-26 US disclosed
US-20250129069-A1 TRIAZOLO WRN INHIBITORS NIMBUS WADJET, INC. 2025-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206738-A1 WRN INHIBITORS WRN, BLM, RECQL ATM 183/4885ALDH1A1 3002/4885KDM4E 3350/4885
US-20250129069-A1 TRIAZOLO WRN INHIBITORS WRN, BLM, RECQL ATM 128/4885ALDH1A1 3394/4885KDM4E 3188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.